Male pattern baldness and its association with coronary heart disease: A meta-analysis

BMJ Open

Volumn 3, Issue 4, 2013, Pages

  Yamada, Tomohide ^a   Hara, Kazuo ^a   Umematsu, Hitomi ^a   Kadowaki, Takashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGINA PECTORIS; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR RISK; COCHRANE LIBRARY; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; HAIR LOSS; HAMILTON SCALE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; MEDLINE; META ANALYSIS (TOPIC); OBSERVATIONAL STUDY; PUBLICATION; RISK FACTOR;

EID: 84877658261     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-002537     Document Type: Article

References (40)

1. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57. (Pubitemid 43767064)
2. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham population. Am Heart J 1986;111:383-90. (Pubitemid 16107280)
3. Young LH, Wackers FJ, Chyun DA, et al. DIAD Investigators. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: A randomized controlled trial. JAMA 2009;301:1547-55.
4. McEvoy JW, Blaha MJ, Nasir K, et al. Impact of coronary computed tomographic angiography results on patient and physician behavior in a low-risk population. Arch Intern Med 2011;171:1260-8.
5. Olsen EA. Androgenetic alopecia. In: Olsen EA, ed. Disorders of hair growth: diagnosis and treatment. New York, NY: McGraw-Hill, 1994:257-83.
6. Hamilton JB. Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 1951;53:708-28.
7. Price VH. Treatment of hair loss. N Engl J Med 1999;341:964-73. (Pubitemid 29441552)
8. Schnohr P, Lange P, Nyboe J, et al. Gray hair, baldness, and wrinkles in relation to myocardial infarction: the Copenhagen City Heart Study. Am Heart J 1995;130:1003-10.
9. Ford ES, Freedman DS, Byers T. Baldness and ischemic heart disease in a national sample of men. Am J Epidemiol 1996;143:651-7. (Pubitemid 26108232)
10. Lotufo PA, Chae CU, Ajani UA, et al. Male pattern baldness and coronary heart disease: the Physicians' Health Study. Arch Intern Med 2000;160:165-71. (Pubitemid 30054335)
11. Lesko SM, Rosenberg L, Shapiro S. A case-control study of baldness in relation to myocardial infarction in men. JAMA 1993;269:998-1003. (Pubitemid 23066636)
12. Miric D, Fabijanic D, Giunio L, et al. Dermatological indicators of coronary risk: A case-control study. Int J Cardiol 1998;67:251-5. (Pubitemid 29029991)
13. Shahar E, Heiss G, Rosamond WD, et al. Baldness and myocardial infarction in men: the atherosclerosis risk in communities study. Am J Epidemiol 2008;167:676-83. (Pubitemid 351430937)
14. Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344-9. (Pubitemid 351289042)
15. Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-Analyses [Internet]. Ottawa Hospital Research Institute. http://www.ohri.ca/programs/clinical- epidemiology/oxford.asp (accessed 4 Dec 2012).
16. DerSimonian R, Laird N. Meta-Analysis in clinical trials. Control Clin Trials 1986;7:177-88. (Pubitemid 17189972)
17. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-Analysis. Stat Med 2002;21:1539-58. (Pubitemid 34746062)
18. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50: 1088-101.
19. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-Analysis detected by a simple, graphical test. BMJ 1997;315:629-34. (Pubitemid 27387172)
20. Stroup DF, Berlin JA, Morton SC, et al. Meta-Analysis of observational studies in epidemiology: A proposal for reporting. Meta-Analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12. (Pubitemid 30214957)
21. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-Analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009;151:W65-94.
22. Norwood OT. Male pattern baldness: classification and incidence. South Med J 1975;68:1359-65.
23. Mumcuoglu C, Ekmekci TR, Ucak S. The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia. Eur J Dermatol 2011;21:79-82.
24. Matilainen V, Koskela P, Keinänen-Kiukaanniemi S. Early androgenetic alopecia as a marker of insulin resistance. Lancet 2000;356:1165-6.
25. Hirsso P, Rajala U, Hiltunen L, et al. Obesity and low-grade inflammation among young Finnish men with early-onset alopecia. Dermatology 2007;214:125-9. (Pubitemid 46377236)
26. Matilainen VA, Mäkinen PK, Keinänen-Kiukaanniemi SM. Early onset of androgenetic alopecia associated with early severe coronary heart disease: A population-based, case-control study. J Cardiovasc Risk 2001;8:147-51. (Pubitemid 32619889)
27. Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol 2004;150:186-94. (Pubitemid 38352454)
28. Scow DT, Nolte RS, Shaughnessy AF. Medical treatments for balding in men. Am Fam Physician 1999;59:2189-94. (Pubitemid 29197944)
29. Su LH, Chen TH. Association of androgenetic alopecia with metabolic syndrome in men: A community-based survey. Br J Dermatol 2010;163:371-7.
30. Ahouansou S, Le Toumelin P, Crickx B, et al. Association of androgenetic alopecia and hypertension. Eur J Dermatol 2007;17:220-2. (Pubitemid 46847785)
31. Arias-Santiago S, Gutiérrez-Salmerón MT, Castellote-Caballero L, et al. Male androgenetic alopecia and cardiovascular risk factors: A case-control study. Actas Dermosifiliogr 2010;101:248-56.
32. Yudkin JS, Stehouwer CD, Emeis JJ, et al. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-8. (Pubitemid 29177345)
33. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9. (Pubitemid 36158034)
34. Hibberts NA, Howell AE, Randall VA. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol 1998;156:59-65. (Pubitemid 28049864)
35. Demark-Wahnefried W, Lesko SM, Conaway MR, et al. Serum androgens: Associations with prostate cancer risk and hair patterning. J Androl 1997;18:495-500. (Pubitemid 27454306)
36. Fujimoto R, Morimoto I, Morita E, et al. Androgen receptors, 5alfa-reductase activity and androgen-dependent proliferation of vascular smooth muscle cells. J Steroid Biochem Mol Biol 1994;50:169-74. (Pubitemid 24265230)
37. Rebora A. Baldness and coronary artery disease: the dermatologic point of view of a controversial issue. Arch Dermatol 2001;137:943-7. (Pubitemid 32641656)
38. Llau ME, Viraben R, Montastruc JL. Drug-induced alopecia: review of the literature. Therapie 1995;50:145-50.
39. Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol 2006;54:824-44.
40. Olsen EA. Iron deficiency and hair loss: the jury is still out. J Am Acad Dermatol 2006;54:903-6.